Skip navigation
Universidade de Brasília
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/44980
Arquivos associados a este item:
Não existem arquivos associados a este item.
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorSantos, Wilson Oliveira-
dc.contributor.authorRamos, Doralina do Amaral Rabello-
dc.contributor.authorAraujo, Antônio Roberto Lucena-
dc.contributor.authorOliveira, Fábio Morato de-
dc.contributor.authorRêgo, Eduardo Magalhães-
dc.contributor.authorPittella-Silva, Fabio-
dc.contributor.authorAraujo, Felipe Saldanha de-
dc.date.accessioned2022-10-04T12:57:22Z-
dc.date.available2022-10-04T12:57:22Z-
dc.date.issued2016-
dc.identifier.citationOLIVEIRA-SANTOS, Wilson et al. Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia. Tumor Biology, [S.l.], v. 37, p. 9473–9481, 2016. DOI: https://doi.org/10.1007/s13277-016-4846-z.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/44980-
dc.language.isoInglêspt_BR
dc.publisherSpringerpt_BR
dc.rightsAcesso Restritopt_BR
dc.titleResidual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemiapt_BR
dc.typeArtigopt_BR
dc.subject.keywordLeucemia linfoide crônica (LLC)pt_BR
dc.subject.keywordCitogenéticapt_BR
dc.subject.keywordCariótipopt_BR
dc.identifier.doihttps://doi.org/10.1007/s13277-016-4846-zpt_BR
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s13277-016-4846-zpt_BR
dc.description.abstract1SET and MYND domain containing 2 (SMYD2) and the SET and MYND domain containing 3 (SMYD3) are the most studied and well-characterized members of SMYD family. It has been demonstrated that their altered expression is associated with the progression of several solid tumors. Nevertheless, whether these methyltransferases exert any impact in chronic lymphocytic leukemia (CLL) remains unknown. Here, we investigated the gene expression profile of SMYD2 and SMYD3 in 59 samples of CLL and 10 normal B cells. The obtained results were associated with white blood cells (WBC) and platelet counts, ZAP-70 protein expression, and cytogenetic analysis. We found that SMYD2 and SMYD3 are overexpressed in CLL patients and, interestingly, patients with residual expression of both genes presented a high WBC count and complex karyotype. Furthermore, a strong correlation between SMYD2 and SMYD3 gene expression was unveiled. Our data demonstrate the association of a residual expression of SMYD2 and SMYD3 with CLL progression indicators and suggests both genes are regulated by a common transcriptional control in this type of cancer. These results may provide the basis for the development of new therapeutic strategies to prevent CLL progression.pt_BR
dc.contributor.affiliationUniversidade de Brasília, Faculdade de Ciências da Saúde, Laboratório de Patologia Molecular do Câncerpt_BR
dc.contributor.affiliationUniversidade de São Paulo, Faculdade de Medicina, Ribeiro Pretopt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.